Search

Displaying results 7721 - 7730 of 10000 in total
  1. Drug

    Parsatuzumab

    go.drugbank.com/drugs/DB14897
    Investigational

    Parsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced

    Categories: Amino Acids, Peptides, and Proteins
  2. Drug

    Anamorelin

    go.drugbank.com/drugs/DB06645
    Investigational

    Categories: Amino Acids, Peptides, and Proteins, Hormones, Hormone Substitutes, and Hormone Antagonists
  3. Drug

    Melrilimab

    go.drugbank.com/drugs/DB16373
    Investigational

    Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma).

    Categories: Amino Acids, Peptides, and Proteins
  4. Drug

    Lentinan

    go.drugbank.com/drugs/DB13480
    Investigational

    Categories: Antineoplastic and Immunomodulating Agents, Compounds used in a research, industrial, or household setting
  5. Drug

    Suvratoxumab

    go.drugbank.com/drugs/DB15172
    Investigational

    Suvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).

    Categories: Amino Acids, Peptides, and Proteins
  6. Drug

    Human interleukin-2

    go.drugbank.com/drugs/DB14865
    Investigational

    Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and ProteinsSynonyms: IL 2, IL-2
  7. Drug

    Archexin

    go.drugbank.com/drugs/DB05971
    Investigational

    Categories: Nucleic Acids, Nucleotides, and Nucleosides
  8. Indication

    Invasive Meningococcal Disease caused by Neisseria meningitidis serogroup C

    go.drugbank.com/conditions/DBCOND0093726
    Drugs: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine · Meningococcal polysaccharide vaccine group C · Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen · Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen · Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
  9. Drug

    Autogene cevumeran

    go.drugbank.com/drugs/DB17497
    Investigational

    Autogene cevumeran is an mRNA-based cancer vaccine targeting an unspecified amount of tumour-associated antigens. It is being investigated for cancers.

  10. Drug

    PV903

    go.drugbank.com/drugs/DB05163
    Experimental

    PV903 is a self administered vaginally delivered recombinant protein for the treatment of recurrent miscarriage, resulting from an intolerant immune response to the developing foetus.